Abstract
Aims
Methods
Results
Conclusions
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Diabetes Research and Clinical PracticeReferences
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.Lancet. 2012; 380: 37-43
- Multimorbidity in younger deprived patients: an exploratory study of research and service implications in general practice.BMC Family Pract. 2008; 9: 6
Australian Bureau of Statistics. National Health Survey: First Result, 2014-15; 2015.
- Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.PLoS Med. 2020; 17e1003094
- Thinking about the burden of treatment.BMJ. 2014; 349g6680
- Multimorbidity: Negotiating priorities and making progress.AFP. 2013; 42: 850-854
- The impact of comorbid chronic conditions on diabetes care.Diab Care. 2006; 29: 725-731
UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837-53.
- The effects of glucose fluctuation on cognitive function and QOL: the functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes.Int J Clin Pract Suppl. 2002; 129: 20-26
Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics. Diab Care 2018;41(6):e92.
- International Consensus on Use of Continuous Glucose Monitoring.Diab Care. 2017; 40: 1631-1640
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.Diab Care. 2019; (dci190028)
- Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.JAMA. 2006; 295: 1681-1687
- Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature.Diab Obes Metab. 2010; 12: 288-298
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.Diab Care. 2019; 42: 400
- Time in range, as a novel metric of glycemic control, is reversely associated with presence of diabetic cardiovascular autonomic neuropathy independent of HbA1c in Chinese Type 2 Diabetes.J Diab Res. 2020; 2020: 5817074
- Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.Diab Care. 2018; 41: 2370-2376
- Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review.PLoS ONE. 2018; 13e0209585
- Impact of multimorbidity count on all-cause mortality and glycaemic outcomes in people with type 2 diabetes: a systematic review protocol.BMJ Open. 2018; 8
- Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort.BMC Med. 2019; 17: 74
- Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.Lancet Diab Endocrinol. 2020; 8: 17-26
- GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice.BMJ Open. 2018; 8e021435
- Update on the General Practice Optimising Structured Monitoring to Improve Clinical Outcomes in Type 2 Diabetes (GP-OSMOTIC) trial: statistical analysis plan for a multi-centre randomised controlled trial.Trials. 2019; 20: 93
- Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus.Med J Aust. 2009; 191: 339-344
- Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support.J Biomed Inform. 2009; 42: 377-381
- Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups.Diab Technol Ther. 2011; 13: 921-928
Freestyle Libre Flash Glucose Monitoring System User's Manual [Available from: https://freestyleserver.com/Payloads/IFU/2017_oct/ART28697-409_rev-A_Web.pdf.
Australian Bureau of Statistics (ABS). Census of population and housing: Socio-economic indexes for areas (SEIFA), Australia; 2011: Australian Bureau of Statistics; 2013 [Available from: http://www.abs.gov.au/ausstats/[email protected]/DetailsPage/2033.0.55.0012011?OpenDocument.
- Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study.BMC Med. 2012; 10: 128
- Relationship between number of medical conditions and quality of care.New Engl J Med. 2007; 356: 2496-2504
- The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c.Diabetol Metabolic Syndrome. 2014; 6: 139
- Glycemic variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1c.Clin Chim Acta. 2016; 461: 146-150